Lilly Launches Direct-to-Consumer Program for Diabetes, Migraine, Weight-Loss Drugs

In a move that sidesteps pharmacy benefit managers, Eli Lilly has launched a direct-to-consumer marketing program that will provide several of the company’s medicines for obesity, migraine, and diabetes at…

Continue ReadingLilly Launches Direct-to-Consumer Program for Diabetes, Migraine, Weight-Loss Drugs